Use of genetically engineered phage to deliver antimicrobial agents to bacteria: An alternative therapy for treatment of bacterial infections

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1301-1307

  Westwater, Caroline ^a   Kasman, Laura M ^a   Schofield, David A ^a   Werner, Phillip A ^a   Dolan, Joseph W ^a   Schmidt, Michael G ^a   Norris, James S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; DNA VACCINE; PROTEIN CHPBK; PROTEIN GEF; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIOPHAGE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; ESCHERICHIA COLI; FEMALE; GENETIC ENGINEERING; IN VITRO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGENY;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL TOXINS; BACTERIOPHAGES; ESCHERICHIA COLI PROTEINS; FEMALE; GENE THERAPY; GENETIC ENGINEERING; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; PLASMIDS;

EID: 0037379524     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1301-1307.2003     Document Type: Article

References (46)

1. Aizenman, E., H. Engelberg-Kulka, and G. Glaser. 1996. An Escherichia coli chromosomal "addiction module" regulated by 3′,5′-bispyrophosphate: a model for programmed bacterial cell death. Proc. Natl. Acad. Sci. USA 93:6059-6063.
2. Alisky, J., K. Iczkowski, A. Rapoport, and N. Troitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15.
3. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
4. Carlton, R. M. 1999. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 47:267-274.
5. Contreras, A., S. Molin, and J. L. Ramos. 1991. Conditional-suicide containment system for bacteria which mineralize aromatics. Appl. Environ. Microbiol. 57:1504-1508.
6. Couturier, M., E. M. Bahassi, and L. Van Melderen. 1998. Bacterial death by DNA gyrase poisoning. Trends Microbiol. 6:269-275.
7. Cryz, S. J., E. Furer, and R. Germanier. 1983. Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect. Immun. 39:1067-1071.
8. Engelberg-Kulka, H., and G. Glaser. 1999. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu. Rev. Microbiol. 53:43-70.
9. Feng, J., K. Yamanaka, H. Niki, T. Ogura, and S. Hiraga. 1994. New killing system controlled by two genes located immediately upstream of the mukB gene in Escherichia coli. Mol. Gen. Genet. 243:136-147.
10. Gerdes, K., A. P. Gultyaev, T. Franch, K. Pedersen, and N. D. Mikkelsen. 1997. Antisense RNA-regulated programmed cell death. Annu. Rev. Genet. 31:1-31.
11. Gerdes, K., L. K. Poulsen, T. Thisted, A. K. Nielsen, J. Martinussen, and P. H. Andreasen. 1990. The hok killer gene family in Gram-negative bacteria. New Biol. 2:946-956.
12. Gotfredsen, M., and K. Gerdes. 1998. The Escherichia coli relBE genes belong to a new toxin-antitoxin gene family. Mol. Microbiol. 29:1065-1076.
13. Holcik, M., and V. N. Iyer. 1997. Conditionally lethal genes associated with bacterial plasmids. Microbiology 143:3403-3416.
14. Institute of Medicine. 1998. Workshop summary, p. 1-7. In P. F. Harrison and J. Lederberg (ed.), Antimicrobial resistance: issues and options. National Academy Press, Washington, D.C.
15. Jensen, R. B., and K. Gerdes. 1995. Programmed cell death in bacteria: proteic plasmid stabilization systems. Mol. Microbiol. 17:205-210.
16. Jensen, L. B., J. L. Ramos, Z. Kaneva, and S. Molin. 1993. A substrate-dependent biological containment system for Pseudomonas putida based on the Escherichia coli gef gene. Appl. Environ. Microbiol. 59:3713-3717.
17. Kasman, L. M., A. Kasman, C. Westwater, J. Dolan, M. G. Schmidt, and J. S. Norris. 2002. Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J. Virol. 76:5557-5564.
18. Klemm, P., L. B. Jensen, and S. Molin. 1995. A stochastic killing system for biological containment of Escherichia coli. Appl. Environ. Microbiol. 61:481-486.
19. Krylov, V. N. 2001. Phage therapy in terms of bacteriophage genetics: hopes, prospects, safety, limitations. Russ. J. Genet. 37:715-730.
20. Kudva, I. T., S. Jelacic, P. I. Tarr, P. Youderian, and C. J. Hovde. 1999. Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl. Environ. Microbiol. 65:3767-3773.
21. Lindberg, A. A. 1973. Bacteriophage receptors. Annu. Rev. Microbiol. 27:205-241.
22. Malmborg, A. C., E. Söderlind, L. Frost, and C. A. K. Borrebaeck. 1997. Selective phage infection mediated by epitope expression on F pilus. J. Mol. Biol. 273:544-551.
23. Masuda, Y., K. Miyakawa, Y. Nishimura, and E. Ohtsubo. 1993. chpA and chpB, Escherichia coli chromosomal homologs of the pem locus responsible for stable maintenance of plasmid R100. J. Bacteriol. 175:6850-6856.
24. Merril, C. R., B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
25. Molenaar, T. J. M., I. Michon, S. A. M. de Haas, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen. 2002. Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 293:182-191.
26. Molin, S., L. Boe, L. B. Jensen, C. S. Kristensen, and M. Givskov. 1993. Suicidal genetic elements and their use in biological containment of bacteria. Annu. Rev. Microbiol. 47:139-166.
27. Molina, L., C. Ramos, M. C. Ronchel, S. Molin, and J. L. Ramos. 1998. Construction of an efficient biologically contained Pseudomonas putida strain and its survival in outdoor assays. Appl. Environ. Microbiol. 64:2072-2078.
28. Norris, J. S., C. Westwater, and D. Schofield. 2000. Prokaryotic gene therapy to combat multidrug resistant bacterial infection. Gene Ther. 7:723-725.
29. Park, S. C., I. Shimamura, M. Fukunaga, K. I. Mori, and T. Nakai. 2000. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl. Environ. Microbiol. 66:1416-1422.
30. Poulsen, L. K., N. W. Larsen, S. Molin, and P. Andersson. 1989. A family of genes encoding a cell-killing function may be conserved in all Gram-negative bacteria. Mol. Microbiol. 3:1463-1472.
31. Poulsen, L. K., A. Refn, S. Molin, and P. Andersson. 1991. The gef gene from Escherichia coli is regulated at the level of translation. Mol. Microbiol. 5:1639-1648.
32. Poulsen, L. K., A. Refn, S. Molin, and P. Andersson. 1991. Topographical analysis of the toxic Gef protein from Escherichia coli. Mol. Microbiol. 5:1627-1637.
33. Rao, L., W. Ross, J. A. Appleman, T. Gaal, S. Leirmo, P. J. Schlax, M. T. Record, Jr., and R. L. Gourse. 1994. Factor independent activation of rrnB P1. An "extended" promoter with an upstream element that dramatically increases promoter strength. J. Mol. Biol. 235:1421-1435.
34. Ronchel, M. C., L. Molina, A. Witte, W. Lutbiz, S. Molin, J. L. Ramos, and C. Ramos. 1998. Characterization of cell lysis in Pseudomonas putida induced upon expression of heterologous killing genes. Appl. Environ. Microbiol. 64:4904-4911.
35. Ronchel, M. C., and J. L. Ramos. 2001. Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation. Appl. Environ. Microbiol. 67:2649-2656.
36. Ronchel, M. C., C. Ramos, L. B. Jensen, S. Molin, and J. L. Ramos. 1995. Construction and behavior of biologically contained bacteria for environmental applications in bioremediation. Appl. Environ. Microbiol. 61:2990-2994.
37. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
38. Schofield, D. A., C. Westwater, J. W. Dolan, M. G. Schmidt, and J. S. Norris. 2001. Controlled expression in Klebsiella pneumoniae and Shigella flexneri using a bacteriophage P1-derived C1-regulated promoter system. J. Bacteriol. 183:6947-6950.
39. Smith, H. W., and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice with phage: its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
40. Smith, H. W., and M. B. Huggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129:2659-2675.
41. Smith, H. W., M. B. Huggins, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1111-1126.
42. Soberón-Chávez, G. 1996. Evaluation of the biological containment system based on the Escherichia coli gef gene in Pseudomonas aeruginosa W51D. Appl. Microbiol. Biotechnol. 46:549-553.
43. Sulakvelidze, A., Z. Alavidze, and J. G. Morris. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
44. Summers, W. C. 2001. Bacteriophage therapy. Annu. Rev. Microbiol. 55:437-451.
45. Wright, J. J., A. Kumar, and R. S. Hayward. 1992. Hypersymmetry in a transcriptional terminator of Escherichia coli confers increased efficiency as well as bidirectionality. EMBO J. 11:1957-1964.
46. Yarmolinsky, M. B. 1995. Programmed cell death in bacterial populations. Science 267:836-837.